Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.

The winners, Nathan Gates, Faith Apostolodes, and Kevin Helm have shared some insights as to what inspired their winning ...

An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D) funding of up ...

Royalty Pharma to provide R&D investment of up to $250 million for Biogen's litifilimab, a potential first-in-class biologic in Phase 3 development for the treatment of lupus. NEW ...

Co (market cap: $42.4 billion) reported robust Q4 2024 earnings, exceeding Wall Street forecasts with adjusted earnings per share (EPS) of $0.99, compared to the expected $0.82. Revenue also surpassed ...